ICAV - USA is a not-for-profit organization, based in the metropolitan Boston area, whose mission is the discovery and development of new medicines for endemic, emergent, or re-emergent infectious diseases, especially those in the developing world. As such, we perform many of the same R&D tasks as any biotechnology or pharmaceutical company focused on human therapeutics, but absent any commercial incentive. ICAV - USA is devoted only to the public good and focuses its efforts on unmet medical needs as well as public health imperatives.
ICAV - USA curently has defined two projects it is pursuing. The first is influenza, which kills roughly 500,000 around the world every year, especially those individuals with compromised immune systems, such as the malnourished and those already ill. A part of our influenza project is focused on pandemic influenza which has the potential to take hundreds of thousands of lives in mere months. ICAV - USA's other major project is on dengue fever, a mosquito-borne viral disease most notable for the vast number of individuals at-risk for dengue infections each year: one-third of the world's population.
As we grow, ICAV - USA will be adding other infectious disease projects, so please stay tuned.